المؤلفون: Zhuang, Jieqin, Dai, Xingzhen, Jin, Zilin, Cai, Hairong, Wu, Qihua, Zhang, Weizhang, Gao, Huanjia, Chen, Bojun

المصدر: Complementary Therapies in Medicine, Vol 60, Iss, Pp 102754-(2021)
Complementary Therapies in Medicine

مصطلحات موضوعية: C, The Control Group, RR, relative risk, SARS, SevereAcuteRespiratorySyndrom, Traditional Chinese medicine, Lianhua qingwen, Other systems of medicine, 0302 clinical medicine, CNKI, Chinese National Knowledge Infrastructure, N, Not clear, FI, Diagnosis and treatment of pneumonia caused by novel coronavirus infection (Trial version 5), 030212 general & internal medicine, Clinical efficacy, Medicine, Chinese Traditional, RCT, randomized controlled trial, SMD, standard mean variance, VIP, Chinese Scientific Journal Database, Clinical Trials as Topic, FO, Diagnosis and treatment of pneumonia caused by novel coronavirus infection (Trial version 4), COVID-19, corona virus disease 2019, Meta-analysis, TCM, traditional Chinese medicine, Complementary and Manual Therapy, China, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), 2019-nCoV, 2019 novel Coronavirus, Article, 03 medical and health sciences, CBM, Chinese Biomedical Literature Database, Internal medicine, T, The Treatment Group, medicine, Humans, Critical condition, Advanced and Specialized Nursing, SARS-CoV-2, business.industry, Significant difference, COVID-19, PRISMA, Preferred Reporting Items for Systematic Review and Meta-Analyses, CI, confidence interval, Clinical trial, Complementary and alternative medicine, LQ, Lianhua Qingwen Granules or Capsules, Observational study, CT, Conventional Treatment, business, RZ201-999, 030217 neurology & neurosurgery, Drugs, Chinese Herbal

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c00b30ffab0d9d95b9565d1e2455a9f7
https://doi.org/10.1016/j.ctim.2021.102754